Apeiron Investment Group is a company.
Key people at Apeiron Investment Group.
Apeiron Investment Group was founded by Christian Angermayer (Founder).
Apeiron Investment Group was founded by Christian Angermayer (Founder).
Apeiron Investment Group is a discretionary investment firm and family office managing approximately $7 billion in internal and external capital, founded and owned by serial entrepreneur Christian Angermayer.[1][3] Its mission centers on bold optimism for a technology-driven future that empowers longer, healthier, and more fulfilling lives, employing a global, multi-strategy approach with teams in New York, London, Berlin, Abu Dhabi, and Malta, and a primary focus on the US.[1] The firm invests across the company lifecycle—from incubating ideas to scaling growth-stage and listed companies—while acting as anchor LP with GP stakes in emerging asset managers; it maintains a generalist, opportunistic philosophy but emphasizes biotech, fintech & crypto, deep-tech (AI, space-tech, cybersecurity), life sciences, media & entertainment, real estate & prop-tech, German SMEs, international financial services, and emerging markets like Africa.[1][2][3] In the startup ecosystem, Apeiron drives impact through direct proprietary investments in innovative private and public companies, fostering breakthroughs in high-growth tech sectors.[1]
Apeiron Investment Group traces its roots to 2015, when it was established as the family office and merchant banking business of Christian Angermayer, a serial entrepreneur.[1][5] Headquartered in Sliema, Malta, with key figures like co-founder and General Partner Fabian Hansen in the US and others in London and Malta, the firm has evolved from a focus on German small- and medium-sized enterprises (spanning old economy to new tech), African emerging markets, financial services, and media/entertainment into a broader global player.[2][3][5] This expansion reflects Angermayer's entrepreneurial background, culminating in recent moves like opening a family office in Abu Dhabi in 2023 to tap UAE's tech ecosystem, alongside managing closed funds and commitments in private equity strategies.[3][5]
Apeiron rides key trends like the convergence of biotech/life sciences with deep-tech (AI, cybersecurity) and fintech/crypto, capitalizing on global shifts toward longevity tech, emerging markets, and prop-tech amid rising demand for scalable innovations.[1][3] Timing aligns with post-2023 expansions into UAE's tech hub, where family offices fuel economic diversification, and a US/UK focus amid maturing private markets.[1][3][4] Market forces favoring it include abundant capital for multi-strategy plays, serial founder networks for deal flow, and opportunistic generalism across private/public assets in high-growth areas like Africa and German tech transitions.[2][5] It influences the ecosystem by anchoring emerging managers, incubating startups, and bridging traditional SMEs with cutting-edge tech, amplifying impact in underserved regions and sectors.[1][2]
Apeiron is poised to deepen UAE and US footholds, scaling its $7B platform toward larger LP/GP plays and biotech/deep-tech bets as AI-driven health tech and crypto mature.[1][3] Trends like longevity innovation, prop-tech urbanization, and African EM growth will shape its path, potentially evolving its influence from nimble family office to major multi-strategy anchor amid rising global capital competition.[1][2][4] This positions Apeiron to sustain its core optimism, fueling tech-empowered lives through bold, lifecycle-spanning investments.[1]
Key people at Apeiron Investment Group.
